Radionetics Oncology
Clinical trials sponsored by Radionetics Oncology, explained in plain language.
-
New 'Find and Treat' approach tested for tough breast cancers
Disease control Recruiting nowThis early-stage study is testing a two-part approach for advanced breast cancer that has returned or spread. First, a new radioactive tracer (68Ga-R11228) is used in a PET scan to find cancer spots in the body. If the scan shows the cancer takes up the tracer, patients may then …
Phase: PHASE1 • Sponsor: Radionetics Oncology • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC
-
New scan aims to sharpen the picture of stubborn breast cancer
Diagnosis Recruiting nowThis early-stage study is testing a new radioactive imaging tracer called 68Ga-R10602 to see if it can better locate tumors in people with advanced, hormone-positive breast cancer. The study will enroll about 36 adults whose cancer has progressed despite prior treatments. The mai…
Phase: PHASE1 • Sponsor: Radionetics Oncology • Aim: Diagnosis
Last updated Mar 30, 2026 14:34 UTC